Showing results (211-220 of 237) with videos related to
Sort By:
Pageof 24
Neuro-Oncology Advances|February 8, 2023
Tandem chimeric antigen receptor (CAR) T cells targeting EGFRvIII and IL-13Rα2 are effective against heterogeneous glioblastomaAndrea Schmidts, Ambike A Srivastava, Rishab Ramapriyan, et al.Cell|April 15, 2014
Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cellsMario L Suvà, Esther Rheinbay, Shawn M Gillespie, et al.Nature Medicine|August 15, 2018
Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumorsPakawat Chongsathidkiet, Christina Jackson, Shohei Koyama, et al.Nature Medicine|January 24, 2019
Author Correction: Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumorsPakawat Chongsathidkiet, Christina Jackson, Shohei Koyama, et al.Neuro-Oncology|April 6, 2024
Radical surgical resection with molecular margins is associated with improved survival in IDH wild-type glioblastomaElie Massaad, William J Smith, Joseph Bradley, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2023
Bavituximab Decreases Immunosuppressive Myeloid-Derived Suppressor Cells in Newly Diagnosed Glioblastoma PatientsK Ina Ly, Leland G Richardson, Mofei Liu, et al.Journal of the National Comprehensive Cancer Network : JNCCN|June 8, 2013
Bone cancerJ Sybil Biermann, Douglas R Adkins, Mark Agulnik, et al.Nature Communications|March 15, 2022
Phase 2 study of pembrolizumab in patients with recurrent and residual high-grade meningiomasPriscilla K Brastianos, Albert E Kim, Anita Giobbie-Hurder, et al.Cancer Cell|December 19, 2015
Extreme Vulnerability of IDH1 Mutant Cancers to NAD+ DepletionKensuke Tateishi, Hiroaki Wakimoto, A John Iafrate, et al.The New England Journal of Medicine|July 12, 2023
BRAF-MEK Inhibition in Newly Diagnosed Papillary CraniopharyngiomasPriscilla K Brastianos, Erin Twohy, Susan Geyer, et al.Pageof 24